Astrana Health (ASTH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.40
- EPS estimate
- $0.34
- EPS surprise
- +19.12%
- Revenue surprise
- −1.33%
- Revenue
- $972.5M
- Revenue estimate
- $985.6M
- Reported
- Aug 6, 2026
Astrana Health reported Q2 2026 results on August 6, 2026. Earnings per share were $0.40, ahead of the $0.34 estimate by 19.12%. Revenue was $972.5 million, 1.33% below the $985.6 million consensus. Compared with Q2 2025, EPS roughly doubled from $0.19 and revenue grew 48.5% from $654.8 million. Revenue was the highest in the table.
The 20 quarters shown tell two different stories. Revenue grew fast: from $1.14 billion in 2022 to $1.39 billion in 2023, $2.03 billion in 2024 and $3.18 billion in 2025, with the biggest step in Q3 2025. Earnings did not keep pace. Annual EPS was $1.06 in 2022 and $1.32 in 2023, then fell to $0.89 in 2024 and $0.46 in 2025. Astrana posted losses in Q4 2022 and Q4 2024, and Q3 2025 earned just $0.01 against a $0.47 estimate. The first half of 2026 adds up to $0.69 per share. Over the 20 quarters, Astrana beat the EPS estimate 14 times and missed 6 times.
Astrana has reported its third-quarter results between November 3 and November 7 in each of the past five years. That points to early November 2026 for Q3 2026. It will show whether earnings keep rising with revenue.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.34 | $0.40 | +19.12% | $972.5M | SEC |
| Q1 2026 | May 7, 2026 | $0.30 | $0.29 | −2.91% | $965.1M | SEC |
| Q4 2025 | Mar 2, 2026 | $0.11 | $0.12 | +6.67% | $950.5M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.47 | $0.01 | −97.86% | $956.0M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.35 | $0.19 | −45.54% | $654.8M | SEC |
| Q1 2025 | May 8, 2025 | $0.21 | $0.14 | −32.37% | $620.4M | SEC |
| Q4 2024 | Feb 27, 2025 | $0.10 | −$0.15 | −251.52% | $665.2M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.31 | $0.33 | +6.73% | $478.7M | SEC |
| Q2 2024 | Aug 7, 2024 | $0.39 | $0.40 | +1.91% | $486.3M | SEC |
| Q1 2024 | May 7, 2024 | $0.30 | $0.31 | +2.48% | $404.4M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.15 | $0.26 | +76.03% | $353.0M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.33 | $0.47 | +42.42% | $348.2M | SEC |
| Q2 2023 | Aug 7, 2023 | $0.25 | $0.28 | +12.40% | $348.2M | SEC |
| Q1 2023 | May 8, 2023 | $0.31 | $0.31 | +1.08% | $337.2M | SEC |
| Q4 2022 | Feb 23, 2023 | −$0.07 | −$0.06 | +14.29% | $294.2M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.32 | $0.56 | +75.82% | $317.0M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.20 | $0.25 | +23.15% | $269.7M | SEC |
| Q1 2022 | May 5, 2022 | $0.32 | $0.31 | −3.13% | $263.3M | SEC |
| Q4 2021 | Feb 24, 2022 | $0.27 | $0.30 | +13.21% | $195.1M | SEC |
| Q3 2021 | Nov 4, 2021 | $0.34 | $0.74 | +117.65% | $227.1M | SEC |
Quarterly revenue
Frequently asked questions
When did Astrana Health (ASTH) last report earnings?
Astrana Health last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did ASTH beat earnings estimates?
Yes. Astrana Health reported EPS of $0.40 for Q2 2026 against a $0.34 estimate — a 19.12% beat.
How much revenue did ASTH report last quarter?
Astrana Health reported $972.5M in revenue for Q2 2026, against a consensus estimate of $985.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.